Your browser doesn't support javascript.
loading
Efficacy and Safety of Ertugliflozin Added to Metformin: A Pooled Population from Asia with Type 2 Diabetes and Overweight or Obesity.
Ji, Linong; Liu, Jie; Xu, Zhi Jin; Wei, Zhiqi; Zhang, Ruya; Malkani, Seema; Cater, Nilo B; Frederich, Robert.
Affiliation
  • Ji L; Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China.
  • Liu J; Global Clinical Development, MRL, Merck & Co., Inc., Rahway, NJ, USA.
  • Xu ZJ; Biostatistics, Merck & Co., Inc., Rahway, NJ, USA.
  • Wei Z; Global Medical Affairs, MRL, MSD China, Shanghai, China.
  • Zhang R; Global Medical Affairs, MRL, MSD China, Shanghai, China.
  • Malkani S; Global Medical and Scientific Affairs, MRL, Merck & Co., Inc., Rahway, NJ, USA.
  • Cater NB; Global Medical Affairs, Pfizer Inc., New York, NY, USA. Nilo.Cater@pfizer.com.
  • Frederich R; Clinical Development and Operations, Pfizer Inc., Groton, CT, USA.
Diabetes Ther ; 14(2): 319-334, 2023 Feb.
Article in En | MEDLINE | ID: mdl-36763328
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Diabetes Ther Year: 2023 Document type: Article Affiliation country: China Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Diabetes Ther Year: 2023 Document type: Article Affiliation country: China Country of publication: United States